RAD BioMed Accelerator in the News - 5 former Rad BioMed portfolio cos raise $7m

Read More >> Read More >>
SoftWheel in the news

Read More >> Read More >>
Now in the Media - The Eon Medical Acquisition by Teleflex!

Read More >> Read More >>
RAD BioMed Accelerator is proud to announce the acquisition of Eon Surgical by Teleflex!

Read More >> Read More >>
Annual Showcase 2013

Read More >> Read More >>
Happy New Year!

Happy 2013!!

Read More >> Read More >>
Discover Medical Devices exhibited at Medica.

Discover Medical Devices, a RAD BioMed portfolio company, exhibited its revolutionary SomnuSeal intra oral CPAP mask at Medica in Dusseldorf Germany  - the largest medical equipment exhibition in the world.

Read More >> Read More >>
VGS, a RAD BioMed portfolio company, attracted a lot of interest at the EACTS conference in Barcelona this week

Read More >> Read More >>
Discover Medical Devices announces additional intermediate results of its second clinical trial with the revolutionary self adaptable intra oral CPAP mask – the SomnuSeal

Discover Medical Devices SomnuSeal masks line are the first CPAP masks that successfully address the problem of non compliance in Obstructive Sleep Apnea patients. The revolutionary SomnuSeal mask has 90% compliance among current users of traditional masks and 26% compliance among non compliant OSA patients that refuse to use any traditional mask.

The novel SomnuSeal masks do not suffer from the side effects of traditional masks and therefore will allow many millions of OSA patients that currently refuse treatment to receive an effective treatment.

Read More >> Read More >>
Annual Showcase event 2012

Rad BioMed Accelerator
cordially invites you to attend the Annual Showcase event 2012

Read More >> Read More >>
ESTIMME PICKED AS HOT COMPANY OF THE MONTH BY CLINICA MAGAZINE

 - EStimME was chosen after presenting initial results of its clinical study at EuroMedtech 2011 -

Tel – Aviv, Israel,  July 20th, 2011 – EStimME (a RAD Biomed Accelerator  portfolio company) has been chosen as hot pick of the month in the July issue of Clinica (http://www.clinica.co.uk/multimedia/archive/00161/MTV_52_161998a.pdf) , a leading publication covering  the international devices and diagnostics industries. EStimME previously presented its technology at EuroMedtech 2011, which was held in Turin, Italy from the 16th to the 17th of May, 2011. (http://www.ebdgroup.com/emt/index.php).

Read More >> Read More >>
EON SURGICAL TO PRESENT ITS MINIMALLY INVASIVE LAPAROSCOPIC TECHNOLOGY AT THE 19th EAES INTERNATIONAL CONGRESS

-- Eon Surgical’s InterTipTM Platform will be featured in the “Amazing Technologies” session --

Tel – Aviv, Israel,  June 5th, 2011 – Eon Surgical (a RAD Biomed Accelerator  portfolio company) announced today that it has been invited to present at the “Amazing Technologies” session  in the 19th International Congress of the European Association for Endoscopic Surgery (EAES), which will be held in Torino, Italy from the 15th to the 18th of June, 2011. (http://congress.eaes.eu/congress2011.aspx). Dr. Yoav Mintz, Director of the Department of General Surgery in Hadassah-University Medical Center in Jerusalem, will present at EAES the first full pre-clinical procedure to be conducted with the InterTipTM.

Read More >> Read More >>
RAD BIOMED’S DISCOVER MEDICAL DEVICES COMMENCES CLINICAL TRIAL OF SLEEP APNEA MASK

-- Discover Medical Devices’ SomnuSeal Mask is Breakthrough Product for Patients with Obstructive Sleep Apnea  --

Tel – Aviv, Israel, March 21st,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that its portfolio company, Discover Medical Devices, has started a second clinical trial for its Somnuseal™ mask for patients with Obstructive Sleep Apnea (OSA)

Read More >> Read More >>
RAD BIOMED ACCELERATOR ADDS SOFTWHEEL TO ITS PORTFOLIO

-- Softwheel  will develop breakthrough solutions in assistive technology aimed at wheelchair users --

Tel – Aviv, Israel, February 17th,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  it has added Softwheel, a new medical device company, to its portfolio. Softwheel will develop a breakthrough technology aimed at wheelchair users.

Read More >> Read More >>
ESTIMME IS FEATURED AS START-UP OF THE WEEK IN GLOBES- ISRAEL'S LEADING BUSINESS DAILY NEWSPAPER

Tel – Aviv, Israel, February 16th,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  its portfolio company EstimME has been featured as "Start-Up of  the Week", by Globes – Israel's leading business daily newspaper. EstimME is developing a minimally invasive device for the treatment of tinnitus. The article (in Hebrew) can be downloaded here (link).

Read More >> Read More >>
RAD BIOMED ACCELERATOR ADDS PLEXICURE TO ITS PORTFOLIO

-- Plexicure is a joint venture between RAD BioMed, Israeli vernture capital Pontifax and Roche Pharmaceuticals --

Tel – Aviv, Israel, January 1st,  2011 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  it has added Plexicure, a new biopharma company that will be developed as a joint venture with Israeli venture capital firm Pontifax , in partnership with Roche AG (SWX: RO).

Read More >> Read More >>
RAD BIOMED ACCELERATOR ADDS DR. SIGAL KREMER-TAL, MD TO ITS TOP MANAGEMENT TEAM

-- Dr.  Kremer Tal joins RAD BioMed from Novartis US --

Tel – Aviv, Israel, December 1st,  2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  Dr. Sigal Kremer-Tal, MD has joined its top management team as the new VP Scouting & Operations. 

Read More >> Read More >>
RAD BIOMED’S VGS TO PRESENT AT TCT 2010

-- VGS to show the latest preclinical results for its FLUENT device  --

Tel  Aviv, Israel, September 21st,  2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that its portfolio company, Vascular Graft Solutions (VGS), has been invited to present this year’s TCT  (Transcatheter Cardiovascular Therapeutics) conference in Washington DC.

Read More >> Read More >>
RAD BIOMED’S AOPHARMA COMPLETES AN INVESTMENT ROUND OF US$2 MILLION

-- The financing round was led by Israeli venture capital firm Coronis Partners --

Tel – Aviv, Israel, May 2nd,  2010 – RAD BioMed, a leading success-accelerator for Israeli life science startups, today announced that  its portfolio company AOPharma has successfully completed a $2 million investment round raised from investors including Coronis Partners – an Investment Company specialized in the Biotechnology sector, Mr. Gur Munzer, owner of Care Medical Services and of Natali and RAD BioMed Accelerator.

Read More >> Read More >>